The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

A groundbreaking cattle genome has given researchers their clearest look yet at what makes Wagyu beef so special. By ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Abstract: Traditional approaches for transmission system voltage control (TSVC) rely heavily on manual action or mathematical optimization methods, which face challenges when addressing the ...